January 26, 2019 – 12:41 AMT
PanARMENIAN.Net – Recent research has linked regular uses of non-infectious anti-inflammatory drugs, such as aspirin, for longer survival in some people with head and neck cancer, Information Doctor's Information Today.
The researchers propose that there is now a clinical attempt to test the effectiveness and security of anti-inflammatory drugs (ASAIDs) for this purpose.
They suggest that the effect they have observed is likely to be due to the NSAIDs reducing prostateland E2, a molecule that promotes inflammation.
A paper about their findings is now presented in the Newspaper of Experimental Medicine.
Cancers of head and neck are cancers, in which tumors evolve in the nose, chairs, larynx, throat and mouth.
In most cases, the tumors arise in the flat thin schematic cells that form the fabric roofs of surfaces. For this reason, they take the name carcinomas of scam cells of head and neck (HNSCC).
In the United States, people with HNSCC represent about 4 percent of all those with cancer. These types of cancer also tend to have a lower rate of survival compared to many other types.
The main risk factors for HNSCC are the use of tobacco, heavy use of alcohol, solar exposure and infection with the human papillometer (HPV).